Author

Lilla Laura Lakner

EFFICACY AND SAFETY OF BIOSIMILAR INFLIXIMAB AFTER ONE-YEAR: RESULTS FROM A PROSPECTIVE NATIONWIDE COHORT

Krisztina Barbara Gecse, Zsuzsanna Vegh, Zsuzsanna Kürti, Mariann Rutka, Klaudia Farkas, János Banai, László Bene, Beata Gasztonyi, Petra Anna Golovics, Barbara Dorottya Lovasz, Tünde Kristóf, László Lakatos, Pal Miheller, Ferenc Nagy, Karoly Palatka, Mária Papp, Lilla Laura Lakner, Árpád V. Patai, Ágnes Szabone Salamon;;

LONG-TERM EFFICACY OF VEDOLIZUMAB THERAPY ON CLINICAL AND ENDOSCOPIC ACTIVITY IN PATIENTS WITH ANTI-TUMOR NECROSIS FACTOR ALPHA RESISTANT INFLAMMATORY BOWEL DISEASE

Renáta Bor, Zoltan Gabor Szepes, Mária Matuz, Klaudia Farkas, Anna Fabian, Pal Miheller, Karoly Palatka, Tamás Szamosi, Aron Vincze, Lilla Laura Lakner, Katalin Müllner, Mária Papp, Ágnes Szabone Dr Salamon, Eszter Schäfer, Krisztina Fülöpné Sarang, Ferenc Nagy, Ferenc Zsigmond, János Banai, Kata Szántó, Anita Balint, M

SHORT AND MEDIUM TERM EFFICACY OF ADALIMUMAB IN ULCERATIVE COLITIS – A MULTICENTRE, PROSPECTIVE OBSERVATIONAL STUDY

Tamás Molnár, Anita Balint, Zoltan Gabor Szepes, Ferenc Nagy, Klaudia Farkas, Renáta Bor, Lilla Laura Lakner, Karoly Palatka, Pal Miheller, Agnes Csontos, Gábor Hegede, Istvan Racz, Aron Vincze, Peter L Lakatos, Petra Anna Golovics, Zoltán Gábor, Mark Juhasz, Ferenc Zsigmond, Tibor Wittmann

Short- and long-term efficacy of vedolizumab therapy on clinical and endoscopic activity in patients with anti-tumor necrosis factor alpha resistant inflammatory bowel disease

Renáta Bor, Klaudia Farkas, Pal Miheller, Karoly Palatka, Tamás Szamosi, Aron Vincze, Mária Matuz, Mariann Rutka, Kata Szántó, Tibor Tóth, Anita Balint, Zoltan Gabor Szepes, Ferenc Nagy, Ágnes Milassin, Anna Fabian, Ferenc Zsigmond, Judit Bajor, Lilla Laura Lakner, Müllner Katalin, Katalin Müllner, Mária Papp, Ágnes Sz

Item 1 - 4 / 4
1